Chenchula S, Varthya SB, Padmavathi R (2022) Rationality, efficacy, tolerability of empagliflozin plus linagliptin combination for the management of type 2 diabetes mellitus: a systematic review of randomized controlled trials and observational studies
Role of GLP analogs (and alternatives) in type 2 diabetes: The goal of drug therapy is generally to keep hemoglobin A1C 9% or if glycemic control is inadequate with a combination of the above-mentioned drugs
Beyond this, research shows that these medications can reduce the risk of major cardiovascular events such as heart attack and stroke
Spread this across your meals and snacks, and include high-quality protein sources like Greek yogurt, salmon, tofu, cottage cheese, or even protein shakes
00:13:14 Don Weinberger: And if you arent a subscriber, dont miss out on these resources
This association persists even in the absence of traditional cardiovascular disease (CVD) risk factors, suggesting a direct relationship between MAFLD and the risk of new-onset HF [39]
